Junhua Lin

652 total citations
21 papers, 509 citations indexed

About

Junhua Lin is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Junhua Lin has authored 21 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Junhua Lin's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Junhua Lin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Junhua Lin collaborates with scholars based in China, United States and Taiwan. Junhua Lin's co-authors include Zhiqiang Meng, Yehua Shen, Litao Xu, Xiangyu Tang, Liping Zhuang, Zhen Chen, Kun Wang, Xiangdong Yang, Luming Liu and Lianyu Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Carcinogenesis and Sustainability.

In The Last Decade

Junhua Lin

20 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junhua Lin China 13 206 107 96 80 78 21 509
Raghu Venkatramanamoorthy United States 11 268 1.3× 128 1.2× 36 0.4× 65 0.8× 89 1.1× 20 528
Ioannis‐Georgios Tzanninis Greece 11 177 0.9× 58 0.5× 82 0.9× 39 0.5× 96 1.2× 12 457
Xiaoyan Ding China 13 158 0.8× 150 1.4× 183 1.9× 87 1.1× 148 1.9× 37 607
Qianru Li China 10 148 0.7× 135 1.3× 31 0.3× 48 0.6× 74 0.9× 26 394
Hideki Ohnishi Japan 16 97 0.5× 143 1.3× 209 2.2× 183 2.3× 59 0.8× 36 646
Marc Hilmi France 15 421 2.0× 171 1.6× 63 0.7× 54 0.7× 128 1.6× 34 716
Yao-Li Chen Taiwan 12 76 0.4× 198 1.9× 55 0.6× 76 0.9× 72 0.9× 29 402
Yanjie Zhao China 17 108 0.5× 436 4.1× 60 0.6× 76 0.9× 244 3.1× 38 784
Viola Barucca Italy 13 343 1.7× 90 0.8× 18 0.2× 82 1.0× 116 1.5× 19 496
Yilin Wu China 11 61 0.3× 191 1.8× 26 0.3× 67 0.8× 123 1.6× 44 431

Countries citing papers authored by Junhua Lin

Since Specialization
Citations

This map shows the geographic impact of Junhua Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhua Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhua Lin more than expected).

Fields of papers citing papers by Junhua Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junhua Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhua Lin. The network helps show where Junhua Lin may publish in the future.

Co-authorship network of co-authors of Junhua Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Junhua Lin. A scholar is included among the top collaborators of Junhua Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junhua Lin. Junhua Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ning, Zhouyu, Lin Xie, Yongqiang Hua, et al.. (2023). Transarterial chemoembolization plus lenvatinib with or without a PD-1 inhibitor for advanced and metastatic intrahepatic cholangiocarcinoma: a retrospective real-world study. British Journal of Radiology. 96(1150). 20230079–20230079. 4 indexed citations
3.
Lin, Junhua, et al.. (2022). RUNX1 and CCL3 in Diabetes Mellitus-Related Coronary Artery Disease: A Bioinformatics Analysis. SHILAP Revista de lepidopterología. 3 indexed citations
4.
Chen, Gang, et al.. (2021). Overexpression of a Long Non-Coding RNA BC037916 is Associated with Pancreatic Tumorigenesis and Poor Prognosis. OncoTargets and Therapy. Volume 13. 13451–13463. 2 indexed citations
5.
Wang, Xiaodong, et al.. (2021). Classifiers for Predicting Coronary Artery Disease Based on Gene Expression Profiles in Peripheral Blood Mononuclear Cells. International Journal of General Medicine. Volume 14. 5651–5663. 7 indexed citations
6.
Cao, Yulin, Yuan Yin, Zhifeng Wu, et al.. (2020). Sublethal irradiation promotes the metastatic potential of hepatocellular carcinoma cells. Cancer Science. 112(1). 265–274. 9 indexed citations
7.
Shen, Yehua, Gang Chen, Liping Zhuang, et al.. (2019). <p>ARHGAP4 mediates the Warburg effect in pancreatic cancer through the mTOR and HIF-1α signaling pathways</p>. OncoTargets and Therapy. Volume 12. 5003–5012. 32 indexed citations
8.
Lin, Junhua, et al.. (2019). Gender Inequality and Adaptive Capacity: The Role of Social Capital on the Impacts of Climate Change in Vietnam. Sustainability. 11(5). 1257–1257. 33 indexed citations
9.
Zhu, Zhenfeng, Litao Xu, Liping Zhuang, et al.. (2018). Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma. OncoTargets and Therapy. Volume 11. 6731–6740. 20 indexed citations
10.
Lin, Junhua. (2017). ‘Assisting you to become a local’: NGOs and constructed foreign spouses in Eastern Taiwan. Gender Place & Culture. 25(1). 118–133. 7 indexed citations
11.
Xu, Litao, Shulin Yu, Liping Zhuang, et al.. (2017). Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients. Oncotarget. 8(21). 34954–34960. 71 indexed citations
12.
Xu, Litao, Shiying Wang, Liping Zhuang, et al.. (2015). Jian Pi Li Qi Decoction Alleviated Postembolization Syndrome Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma. Integrative Cancer Therapies. 15(3). 349–357. 23 indexed citations
13.
Chen, Lianyu, Kun Wang, Zhen Chen, et al.. (2015). High intensity focused ultrasound ablation for patients with inoperable liver cancer.. PubMed. 62(137). 140–3. 13 indexed citations
14.
Wang, Kun, Huili Zhu, Zhiqiang Meng, et al.. (2013). Safety Evaluation of High-Intensity Focused Ultrasound in Patients with Pancreatic Cancer. Oncology Research and Treatment. 36(3). 88–92. 44 indexed citations
15.
Wang, Kun, Lianyu Chen, Zhiqiang Meng, et al.. (2012). High intensity focused ultrasound treatment for patients with advanced pancreatic cancer: A preliminary dosimetric analysis. International Journal of Hyperthermia. 28(7). 645–652. 8 indexed citations
16.
Tang, Xiangyu, Qiong Jiang, Qing Liu, et al.. (2012). Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with type 2 diabetes.. Clinical Laboratory. 58(5-6). 539–44. 24 indexed citations
17.
Shi, Weidong, Zhiqiang Meng, Zhen Chen, et al.. (2011). RNA interference against MDM2 suppresses tumor growth and metastasis in pancreatic carcinoma SW1990HM cells. Molecular and Cellular Biochemistry. 387(1-2). 1–8. 15 indexed citations
18.
19.
Wang, Kun, Zhen Chen, Zhiqiang Meng, et al.. (2011). Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer. International Journal of Hyperthermia. 27(2). 101–107. 78 indexed citations
20.
Tang, Xiangyu, et al.. (2009). Protective Effects of Lycopene against H2O2-Induced Oxidative Injury and Apoptosis in Human Endothelial Cells. Cardiovascular Drugs and Therapy. 23(6). 439–448. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026